Moxetumomab Pasudotox-tdfk and Tetrahydrozoline (Nasal)
Determining the interaction of Moxetumomab Pasudotox-tdfk and Tetrahydrozoline (Nasal) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: tetrahydrozoline nasal
Brand name: Tyzine
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Tetrahydrozoline and zinc ophthalmic
- Moxetumomab Pasudotox-tdfk-Tetrahydrozoline Hydrochloride
- Moxetumomab Pasudotox-tdfk-Tetrahydrozoline ophthalmic
- Moxetumomab Pasudotox-tdfk-Tetrofosmin
- Moxetumomab Pasudotox-tdfk-Tetterine
- Moxetumomab Pasudotox-tdfk-Tetterine Topical
- Tetrahydrozoline (Nasal)-Moxetumomab pasudotox-tdfk Intravenous
- Tetrahydrozoline (Nasal)-Moxifloxacin
- Tetrahydrozoline (Nasal)-Moxifloxacin (Systemic)
- Tetrahydrozoline (Nasal)-Moxifloxacin Hydrochloride
- Tetrahydrozoline (Nasal)-Moxifloxacin Injection
- Tetrahydrozoline (Nasal)-Moxifloxacin Intravenous